Catch up on today's top five initiations upgrades with this list compiled by The Fly: 1. Aeglea BioTherapeutics (AGLE) initiated with a Buy at UBS and an Outperform at BMO Capital and Wells Fargo. UBS analyst Jeffrey Hung said initial data indicate that AEB1102 should work in lowering plasma arginine levels. 2. Ferrellgas Partners LP (FGP) initiated with a Sector Perform at RBC Capital. 3. Platform Specialty Products (PAH) assumed with a Neutral at Credit Suisse. 4. MPLX (MPLX) initiated with an Outperform at RBC Capital. 5. TerraForm Power (TERP) reinstated with a Neutral at Goldman. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.